Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours

Journal of Pathology

Volumn 207, Issue 3, 2005, Pages 336-345

  Allia, Elena ^a   Tarabra, Elena ^a   Volante, Marco ^a   Cerrato, Milena ^a   Ghigo, Ezio ^b   Muccioli, Giampiero ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cortistatin; Immunohistochemistry; MrgX2 receptor; Neuroendocrine tumours; RT PCR; Somatostatin

Indexed keywords

CORTISTATIN; HYPOPHYSIS HORMONE; MESSENGER RNA; NEUROPEPTIDE; ONCOPROTEIN; PROTEIN MRGX2; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ADRENAL GLAND; ARTICLE; BLOOD VESSEL; BRAIN CORTEX; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS CELL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG; LYMPHOCYTE; NEUROENDOCRINE TUMOR; OVARY; PARATHYROID CELL; PARATHYROID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS; THYROID GLAND;

CARCINOMA, NEUROENDOCRINE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 27644531496     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1839     Document Type: Article

References (31)

1. Spier AD, de Lecea L. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 2000;33:228-241.
2. de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 1996;381:242-245.
3. Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakamoto J, Miyamoto M, et al. Identification and characterization of a novel human cortistatin-like peptide. Biochem Biophys Res Commun 1997;232:157-163.
4. De Lecea L, Ruiz-Lozano P, Danielson PE, Peelle-Kirley J, Foye PE, Frankel WN, et al. Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. Genomics 1997;42:499-506.
5. Ejeskar K, Abel F, Sjoberg RM, Backstrom J, Kogner P, Martinsson T. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-p36.2, but absence of mutation in primary tumours. Cytogenet Cell Genet 2000;89:62-66.
6. 10-Cortistatin-14 labels all five somatostatin receptors. Naunyn-Schmiedebergs Arch Pharmakol 1998; 357:483-489.
7. Deghenghi R, Papotti M, Ghigo E, Muccioli G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptor of human pituitary gland. J Endocrinol Invest 2001;24:RC1-RC3.
8. Deghenghi R, Broglio F, Papotti M, Muccioli G, Ghigo E. Targeting the ghrelin receptor. Orally active GHS and cortistatin analogs. Endocrine 2003;22:13-18.
9. Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Grottoli S, et al. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 2002;87:3783-3790.
10. Kreienkamp HJ. Molecular biology of the receptors for somatostatin and cortistatin. Results Probl Cell Differ 1999;26:215-237.
11. Reichlin S. Neuroendocrinology. In Williams Textbook of Endocrinology (9th edn), Wilson JD (ed). WB Saunders: Philadelphia, 1998; 165-248.
12. Robas N, Mead E, Fidock M. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 2003;278:44400-44404.
13. De Lecea L, del Rio JA, Criado JR, Alcantara S, Morales M, Danielson PE, et al. Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci 1997;17:5868-5880.
14. Papotti M, Tarabra E, Allia E, Bozzalla Cassione F, Broglio F, Deghenghi R, et al. Presence of cortistatin in the human pancreas. J Endocrinol Invest 2003;26:RC15-RC18.
15. Dalm VA, Van Hagen PM, Van Koetsveld PM, Langerak AW, Van Der Lely AJ, Lamberts SW, et al. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. J Clin Endocrinol Metab 2003;88:270-276.
16. Cassoni P, Muccioli G, Marrocco T, Volante M, Allia E, Ghigo E, et al. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin. J Endocrinol Invest 2002;25:362-368.
17. Notas G, Kolios G, Mastrodimou N, Kampa M, Visilaki A, Xidakis C, et al. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors. J Hepatol 2004;40:792-798.
18. Merz JF, Sankar P, Taube SE, LiVolsi VA. Use of human tissues in research: clarifying clinician and researcher roles and information flows. J Invest Med 1997;45:252-257.
19. Bongiovanni M, Viberti L, Pecchioni C, Papotti M, Thonhofer R, Popper H, et al. Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells. J Pathol 2002;198:252-257.
20. Papotti M, Bongiovanni M, Volante M, Allia E, Landolfi S, Helboe L, et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumours. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch 2002;440:461-475.
21. Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumours. J Clin Endocrinol Metab 2002;87:1300-1308.
22. Papotti M, Kumar U, Volante M, Pecchioni C, Patel YC. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Clin Endocrinol 2001;54:641-649.
23. Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M, et al. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy. Virchows Arch 2001;439:787-797.
24. Papotti M, Croce S, Macrì L, Funaro A, Pecchioni C, Schindler M, et al. Correlative immunohistochemical and reverse transcriptase-polymerase chain reaction analysis of somatostatin receptor 2 in neuroendocrine tumours of the lung. Diagn Mol Pathol 2000;9:47-57.
25. Dayal Y. Endocrine cells of the gut and their neoplasms. In Pathology of the Colon, Small Intestine and Anus, Norris HT (ed). Churchill Livingstone: New York, 1983; 267-300.
26. Broglio F, Koetsveld PvP, Benso A, Gottero C, Prodam F, Papotti M, et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002;87:4829-4832.
27. Khan A, Tischler AS, Patwardhan NA, DeLellis RA. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study. Endocr Pathol 2003;14:249-255.
28. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumours. Endocr Rev 2004;25:458-511.
29. Sauter GP, Jones DL, Morgan JM, Neonakis E, Woodhead JS, Wheel MH. Role of octreotide on release of intact 1-84 parathyroid hormone from human parathyroid cells. Br J Surg 1998;85:1133-1137.
30. Zielke A, Hasse C, Bruns C, Sitter H, Rothmund M. Octreotide: effective treatment for hyperparathyroidism? A prospective, randomized, controlled clinical trial. Surgery 1997;121:606-610.
31. Dalm VA, Van Hagen PM, De Krijger RR, Kros JM, Van Koetsveld PM, Van Der Lely AJ, et al. Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues. Clin Endocrinol (Oxford) 2004;60:625-629.